mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.02 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.02 |